Document is current
Any future updates will be listed below
-
Authors
Corben, Louise A. https://orcid.org/0000-0001-8767-4582
Collins, Veronica
Milne, Sarah
Farmer, Jennifer
Musheno, Ann
Lynch, David
Subramony, Sub
Pandolfo, Massimo
Schulz, Jörg B.
Lin, Kim
Delatycki, Martin B.
,
Akhlaghi, Hamed
Bidichandani, Sanjay I.
Boesch, Sylvia
Cnop, Miriam
Corti, Manuela
Duquette, Antoine
Durr, Alexandra
Eigentler, Andreas
Emmanuel, Anton
Flynn, John M.
Foroush, Noushin Chini
Fournier, Anne
França, Marcondes C. Jr
Giunti, Paola
Goh, Ellen W.
Graf, Lisa
Hadjivassiliou, Marios
Huckabee, Maggie-Lee
Kearney, Mary G.
Koeppen, Arnulf H.
Lie, Yenni
Lin, Kimberly Y.
Lowit, Anja
Mariotti, Caterina
Mathews, Katherine
McCormack, Shana E.
Montenegro, Lisa
Morlet, Thierry
Naeije, Gilles
Panicker, Jalesh N.
Parkinson, Michael H.
Patel, Aarti
Payne, Ronald Mark
Perlman, Susan
Peverill, Roger E.
Pousset, Francoise
Puccio, Hélène
Rai, Myriam
Rance, Gary
Reetz, Kathrin
Rowland, Tennille J.
Sansom, Phoebe
Savvatis, Konstantinos
Schalling, Ellika T.
Schöls, Ludger
Smith, Barbara
Soragni, Elisabetta
Spencer, Caroline
Synofzik, Matthis
Szmulewicz, David J.
Tai, Geneieve
Tamaroff, Jaclyn
Treat, Lauren
Carpentier, Ariane Veilleux
Vogel, Adam P.
Walther, Susan E.
Weber, David R.
Weisbrod, Neal J.
Wilmot, George
Wilson, Robert B.
Yoon, Grace
Zesiewicz, Theresa
-
Funding
Funding for this research was provided by:
Friedreich's Ataxia Research Alliance
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 30 October 2022
First Online: 12 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: VC, SM, KL, JBS, SS, DL and LAC have no competing interests to report. MBD has research funding from the Friedreich's Ataxia Research Alliance, National Health and Medical Research Council (Australia) and Medical Research Future Fund (Australia). MP has research funding from the Friedreich's Ataxia Research Alliance and is a consultant with Design Therapeutics, Aavantibio, Larimar, Minoryx for the development of FRDA therapeutics. JF and AM are employees of the Friedreich’s Ataxia Research Alliance.
